Experience in using secukinumab in patients with axial psoriatic arthritis
Axial skeletal injury is observed in 25–70% of patients with psoriatic arthritis (PsA). Spondylitis frequently occurs subclinically, which leads to serious structural and functional disorders over time. An update shows that axial skeleton involvement in PsA is characterized by a more severe clinical...
Saved in:
Main Authors: | E. E. Gubar, Yu. L. Korsakova, E. Yu. Loginova, T. V. Korotaeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2020-11-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/1082 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SUCCESSFUL USE OF AN INTERLEUKIN 17 INHIBITOR (SECUKINUMAB) IN THE TREATMENT OF ISOLATED DESTRUCTIVE ENTHESITIS IN PSORIATIC ARTHRITIS
by: E. E. Gubar, et al.
Published: (2018-11-01) -
Involvement of the axial skeleton in psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2017-03-01) -
Clinical and instrumental characteristics of axial psoriatic arthritis in combination with hyperuricemia
by: Yu. L. Korsakova, et al.
Published: (2024-08-01) -
Diagnostic algorithm for axial involvement in psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2025-03-01) -
Differential diagnosis of axial spondyloarthritis and psoriatic arthritis with axial involvement
by: E. E. Gubar, et al.
Published: (2025-06-01)